Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging.

Pasqualini R, Moeller BJ, Arap W.

Semin Thromb Hemost. 2010 Apr;36(3):343-51. doi: 10.1055/s-0030-1253456. Epub 2010 May 20. Review.

PMID:
20490984
2.

The glycan profile of endothelial cells in the present of tumor-conditioned medium and potential roles of beta-1,6-GlcNAc branching on HUVEC conformation.

Peng Y, Li J, Geng M.

Mol Cell Biochem. 2010 Jul;340(1-2):143-52. doi: 10.1007/s11010-010-0411-z. Epub 2010 Mar 5.

PMID:
20204678
3.

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ.

J Clin Oncol. 2009 May 1;27(13):2231-7. doi: 10.1200/JCO.2008.20.0238. Epub 2009 Mar 23.

PMID:
19307500
4.

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.

Bieker R, Kessler T, Schwöppe C, Padró T, Persigehl T, Bremer C, Dreischalück J, Kolkmeyer A, Heindel W, Mesters RM, Berdel WE.

Blood. 2009 May 14;113(20):5019-27. doi: 10.1182/blood-2008-04-150318. Epub 2009 Jan 28.

5.

CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.

Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y, Yanagihara K, Sakai R.

Am J Pathol. 2008 Jun;172(6):1729-39. doi: 10.2353/ajpath.2008.070981. Epub 2008 May 8.

6.

Molecular characterization of human breast tumor vascular cells.

Bhati R, Patterson C, Livasy CA, Fan C, Ketelsen D, Hu Z, Reynolds E, Tanner C, Moore DT, Gabrielli F, Perou CM, Klauber-DeMore N.

Am J Pathol. 2008 May;172(5):1381-90. doi: 10.2353/ajpath.2008.070988. Epub 2008 Apr 10.

7.

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Kodibagkar VD, O'Kelly S, Kulkarni P, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE.

Clin Cancer Res. 2008 Mar 1;14(5):1377-85. doi: 10.1158/1078-0432.CCR-07-1516.

8.

Tumor vascular proteins as biomarkers in ovarian cancer.

Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, Katsaros D, Sandaltzopoulos R, Liotta LA, Gimotty PA, Coukos G.

J Clin Oncol. 2007 Mar 1;25(7):852-61.

PMID:
17327606
9.

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.

Lu C, Bonome T, Li Y, Kamat AA, Han LY, Schmandt R, Coleman RL, Gershenson DM, Jaffe RB, Birrer MJ, Sood AK.

Cancer Res. 2007 Feb 15;67(4):1757-68.

10.

Matriptase and its putative role in cancer.

Uhland K.

Cell Mol Life Sci. 2006 Dec;63(24):2968-78. Review.

PMID:
17131055
11.

TSG-6: a pluripotent inflammatory mediator?

Milner CM, Higman VA, Day AJ.

Biochem Soc Trans. 2006 Jun;34(Pt 3):446-50. Review.

PMID:
16709183
12.

Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment.

Buckanovich RJ, Sasaroli D, O'brien-Jenkins A, Botbyl J, Conejo-Garcia JR, Benencia F, Liotta LA, Gimotty PA, Coukos G.

Cancer Biol Ther. 2006 Jun;5(6):635-42. Epub 2006 Jun 9.

PMID:
16627987
13.

Angiogenesis.

Folkman J.

Annu Rev Med. 2006;57:1-18. Review.

PMID:
16409133
14.

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D.

Nature. 2005 Dec 8;438(7069):820-7.

15.

Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes.

García-Vallejo JJ, Van Dijk W, Van Het Hof B, Van Die I, Engelse MA, Van Hinsbergh VW, Gringhuis SI.

J Cell Physiol. 2006 Jan;206(1):203-10.

PMID:
16080149
16.

Adhesion signaling by a novel mitotic substrate of src kinases.

Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS, Moasser MM.

Oncogene. 2005 Aug 11;24(34):5333-43.

17.

Tumour vascular targeting.

Neri D, Bicknell R.

Nat Rev Cancer. 2005 Jun;5(6):436-46. Review.

PMID:
15928674
18.

Disrupting tumour blood vessels.

Tozer GM, Kanthou C, Baguley BC.

Nat Rev Cancer. 2005 Jun;5(6):423-35. Review.

PMID:
15928673
19.

Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer.

Belani CP, Ramalingam S.

Clin Lung Cancer. 2005 Mar;6(5):267-8. No abstract available.

PMID:
15845175
20.

Imaging angiogenesis: applications and potential for drug development.

Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH.

J Natl Cancer Inst. 2005 Feb 2;97(3):172-87. Review.

PMID:
15687360

Supplemental Content

Support Center